基于风险分层的房颤筛查:AI心电图模型VITAL-AF试验分析
VITAL-AF集群随机试验纳入30,630例无房颤的≥65岁初级保健患者,其中16,937例有院前12导联心电图,采用CHARGE-AF临床评分、ECG-AI模型及两者联合模型评估2年房颤风险。联合模型判别力AUROC为0.788,其最高风险十分位者接受筛查可使2年房颤诊断率差值达2.32/100人年,每筛查43人/年可多诊断1例房颤。
要点
- ECG-AI联合临床因素(CH-AI)可有效识别房颤高危个体,AUROC达0.788。
- CH-AI最高风险十分位人群筛查获益显著,每筛查43人/年可多诊断1例房颤。
- 风险分层筛查需权衡筛查效率与人群覆盖范围。
核心结论
- 基于ECG的AI模型联合临床因素可识别房颤极高危个体,该人群可能从筛查中获益。
研究设计与样本
- VITAL-AF为集群随机试验,纳入16家麻省总医院附属初级保健诊所的≥65岁患者。
- 共30,630例无房颤患者,其中16,937例有入组前3年内至少一次12导联心电图及临床数据。
主要发现
- CHARGE-AF、ECG-AI、CH-AI的2年房颤AUROC分别为0.711(95%CI 0.671-0.749)、0.784(95%CI 0.743-0.819)、0.788(95%CI 0.754-0.824)。
- 平均精度分别为0.0952(95%CI 0.0836-0.112)、0.132(95%CI 0.113-0.157)、0.133(95%CI 0.117-0.159)。
- CH-AI最高风险十分位中,筛查组房颤诊断率10.07/100人年(95%CI 8.28-11.87),对照组7.76/100人年(95%CI 6.30-9.21),P<0.05。
- 对应诊断率差值为2.32/100人年(95%CI 0.01-4.63),每年需筛查人数为43。
临床怎么用
- 可考虑使用ECG-AI联合临床评分对≥65岁人群进行房颤风险分层,聚焦最高风险十分位进行筛查。
局限性
- 研究提示风险分层筛查需权衡筛查效率与人群覆盖范围。
- 尚需进一步研究确定基于风险的方法是否最优,以及纳入医疗可及性等系统因素能否优化筛查策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Screening for atrial fibrillation (AF) may lead to earlier detection and initiation of preventive measures. Current AF screening approaches using a guideline age-based threshold of ≥65 years have shown limited yield. OBJECTIVES: In an AF screening trial, we assessed whether the screening effect was larger among individuals at elevated AF risk using validated clinical and electrocardiogram (ECG)-based artificial intelligence (AI) risk models. METHODS: VITAL-AF was a cluster-randomized trial of patients aged ≥65 years treated at 1 of 16 primary care practices affiliated with Massachusetts General Hospital. Patients randomized to a screening practice were screened using a single-lead ECG. Among VITAL-AF participants without prevalent AF with at least one 12-lead ECG within 3 years before enrollment, we estimated AF risk using 3 validated models derived outside of VITAL-AF: the Cohorts of Heart and Aging Research in Genomic Epidemiology-AF (CHARGE-AF) clinical score, an AI-based model using a 12-lead ECG alone (ECG-AI), and a model combining ECG-AI and CHARGE-AF (CH-AI). Two-year incident AF discrimination was assessed by the time-dependent area under the receiver-operating characteristic curve (AUROC) and average precision. AF screening effect was defined as the difference in 2-year incident AF diagnosis rate (per 100 person-years) in screening vs control across AF risk deciles. RESULTS: Of 30,630 VITAL-AF participants without prevalent AF, 16,937 had pretrial ECG and clinical data. Each score discriminated 2-year AF risk according to AUROC (CHARGE-AF: 0.711 [95% CI: 0.671-0.749]; ECG-AI: 0.784 [95% CI: 0.743-0.819]; CH-AI: 0.788 [95% CI: 0.754-0.824]) and average precision (0.0952 [95% CI: 0.0836-0.112]; 0.132 [95% CI: 0.113-0.157]; 0.133 [95% CI: 0.117-0.159]). An AF screening effect was observed in the top decile of CH-AI (AF diagnosis rate in screening 10.07/100 person-years [95% 8.28-11.87] vs 7.76 [95% 6.30-9.21] in control, P < 0.05), corresponding to a difference in AF diagnosis rate of 2.32/100 person-years (95% CI: 0.01-4.63) and number-needed-to-screen of 43 per year. CONCLUSIONS: Use of ECG-based AI and clinical factors identified individuals at particularly high risk for AF who may benefit from screening. Findings suggest a trade-off between increasing AF screening efficiency and decreasing population coverage (ie, restriction of the screening pool). Future studies are needed to determine whether a risk-based approach is optimal or whether consideration of additional clinical- and systems-level factors (eg, access, health care system engagement) can further refine AF screening strategies. (Screening for Atrial Fibrillation Among Older Patients in Primary Care Clinics [VITAL-AF]; NCT03515057).
引用
- Vedage NA, Friedman SF, Chang Y, et al. Risk-Guided Atrial Fibrillation Screening With Artificial Intelligence-Enabled Electrocardiogram Models: A VITAL-AF Trial Analysis. J Am Coll Cardiol. 2026. PMID: 41983618. doi:10.1016/j.jacc.2026.01.087
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。